Skip to content

Organisation Description

Protexin Healthcare is dedicated to producing innovative, research based live bacteria products of the highest quality for the veterinary, human, agriculture and equine healthcare markets. The natural supplements Protexin manufacture are extensively researched for safety and efficacy. Protexin work closely with leading universities and research centres around the world on a range of ongoing research programmes.

CPD Courses and Workshops Available

  • IBS - the microbiota; nutrition and probiotics

    Seminar | Protexin

    The exact pathophysiology of irritable bowel syndrome (IBS) remains undiscovered; however; substantial recent evidence points to a dysregulated microbiota-gut-brain axis. The gut microbiota is vital for numerous physiological processes and an imbalance; called dysbiosis; is associated with a wide range of diseases. The use of beneficial bacteria (probiotics) has demonstrated effectiveness in acute gastroenteritis; ulcerative colitis; irritable bowel syndrome and many others. During this talk participants will learn about the factors influencing the microbiota; the link between IBS and the human microbiome; and the most up to date evidence on the use of beneficial bacteria supplements in IBS patients.

  • Human microbiota and beneficial bacteria in paediatric research

    Seminar | Protexin

    Imbalance of natural gut microbiota (dysbiosis); has recently been linked to many conditions. Use of beneficial bacteria (probiotics) was successful as alternative or adjunct treatment in antibiotic associated diarrhoea; acute gastroenteritis; infantile colic and many others. During this talk you will learn how human microbiome influences our health; what conditions present with dysbiosis and what is the most up to date evidence on the use of beneficial bacteria supplements in paediatric patients.

  • Probiotics for the prevention and control of infections: Current research

    Seminar | Protexin

    Imbalance of natural gut microbiota (dysbiosis); has recently been linked to many conditions. Nosocomial infections are associated with dysbiosis; paving the way for disease progression. During this talk you will learn how human microbiome influences our health; the impact of a range of nosocomial infections (CDI; UTI; SSI); and the most up to date evidence on the use of beneficial bacteria supplements for hospitalised patients.